Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jennifer Kinsbruner Bush | F | 49 |
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | 4 years |
| Richard Fair | M | 55 | 7 years | |
| Fred Aslan | M | 49 |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | 3 years |
| Elizabeth Hougen | F | 62 |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | 3 years |
| Linda Kozick | F | 66 |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | 3 years |
| Laura Stoppel | M | 38 |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | 4 years |
| Yvonne Yamanaka | M | 38 |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | 4 years |
| Yong-Jun Huh | M | 49 |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | 5 years |
| Brian Daniels | M | 65 |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | 4 years |
| Peter D. Flynn | M | 50 |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | 4 years |
| Heather Raymon | M | - |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alan Musso | M | 62 | 4 years | |
| Jon Stonehouse | M | 63 | 10 years | |
| Kirk Chin Kee | M | 62 |
University of Cambridge
| 8 years |
| Dennis K. Stone | M | 72 | - | |
| Manu Bhaskaran | M | 66 |
University of Cambridge
| 6 years |
| Kin Wah Mak | M | 67 |
University of Cambridge
| 4 years |
| Jonathan Mark Huntley | M | - |
University of Cambridge
| 8 years |
| Bong Koh | M | - |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | - |
| Geoffrey G. Davis | M | - |
University of Cambridge
| 7 years |
| Alan K. Smith | M | 68 | 5 years | |
| Kenneth Ray Moseley | M | 67 | - | |
| R. Dominic King-Smith | M | - |
University of Cambridge
| 7 years |
| Anthony Ian Walker | M | - |
University of Cambridge
| 6 years |
| Anne Frese | F | - |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | 6 years |
| Tony Alves | M | 62 |
University of Cambridge
| 6 years |
| James Farrell Brown | M | 59 | 11 years | |
| Joseph Howard Senesac | M | - | 12 years | |
| Reid Huber | M | 52 | 10 years | |
| Khaled Asad Nasr | M | 66 |
University of Cambridge
| 3 years |
| Alastair K. Livesey | M | 67 |
University of Cambridge
| 3 years |
| Fiona Claire Reynolds | F | 66 |
University of Cambridge
| 5 years |
| Hugh Anthony Simons | M | - |
University of Cambridge
| 3 years |
| Michael John Wilson | M | - |
University of Cambridge
| 8 years |
| John Simon Hunt | M | 61 |
University of Cambridge
| 4 years |
| James Daly | M | 62 | 8 years | |
| Stephen Davis | M | 63 | 9 years | |
| Martin Roper | M | 61 |
University of Cambridge
| 5 years |
| Julian Healy | M | 62 |
University of Cambridge
| 5 years |
| Mark Borwick | M | - |
University of Cambridge
| 3 years |
| Ram shenoy | M | - |
University of Cambridge
| 3 years |
| Beatriz Pessoa de Araujo | F | - |
University of Cambridge
| 7 years |
| Luca Anderlini | M | 66 |
University of Cambridge
| 5 years |
| Paula Disberry | F | 56 |
University of Cambridge
| 5 years |
| Hwee Hua Lim | F | 65 |
University of Cambridge
| 6 years |
| Teck Huat Tan | M | 63 |
University of Cambridge
| 4 years |
| Annemarie B. Moseley | M | 68 | 6 years | |
| Roy Merritt | M | 60 |
University of Cambridge
| 4 years |
| Angus Porter | M | 67 |
University of Cambridge
| 4 years |
| Paul J. Carter | M | - |
University of Cambridge
| 8 years |
| Chong Kiat Lim | M | 68 |
University of Cambridge
| 7 years |
| Frank B. McGuyer | M | 72 | 9 years | |
| Peter Foster | M | 64 |
University of Cambridge
| 4 years |
| Robert Robinson | M | - |
University of Cambridge
| 3 years |
| Steven Berger | M | - |
University of Cambridge
| 4 years |
| Ian Marcus | M | 65 |
University of Cambridge
| 4 years |
| John Ryding | M | - |
University of Cambridge
| 4 years |
| Krishna N Ganesh | M | - |
University of Cambridge
| 3 years |
| Mark Rollins | M | 59 |
University of Cambridge
| 1 years |
| Dame Anne Glover | M | - |
University of Cambridge
| 3 years |
| Simon Rendell | M | 62 |
University of Cambridge
| 3 years |
| Timothy Clissold | M | 64 |
University of Cambridge
| 4 years |
| Zainun binti Ali | F | 72 |
University of Cambridge
| 3 years |
| John Davison | M | - |
University of Cambridge
| 4 years |
| Matthew Holt | M | - |
University of Cambridge
| 3 years |
| Alison Beckett | F | 62 |
University of Cambridge
| 3 years |
| James Witter | M | - |
University of Cambridge
| 3 years |
| Edwin Tai Chiu Cheng | M | 67 |
University of Cambridge
| 3 years |
| Hin Sum Tong | M | 87 |
University of Cambridge
| 4 years |
| Ronjon Nag | M | - |
University of Cambridge
| 4 years |
| Peter Fuhrman | M | 65 |
University of Cambridge
| 1 years |
| Antony D. Buss | M | - |
University of Cambridge
| 3 years |
| Jeremy Levin | M | 70 |
University of Cambridge
| 2 years |
| Mark R. Hemingway | M | - |
University of Cambridge
| 3 years |
| Kwok-Kuen Leong | M | 63 |
University of Cambridge
| 4 years |
| Jonathan Jones | M | - |
University of Cambridge
| 3 years |
| Ian Metcalfe | M | 66 |
University of Cambridge
| 3 years |
| Richard Horlick | M | 65 |
University of Cambridge
| 1 years |
| Alan Richardson | M | - |
University of Cambridge
| 4 years |
| Pierre Francotte | M | 67 |
University of Cambridge
| 4 years |
| Berjis Minoo Desai | M | 67 |
University of Cambridge
| 3 years |
| Ian Hunter | M | - |
University of Cambridge
| 4 years |
| Charles E. Forrest | M | - |
University of Cambridge
| 3 years |
| John Bailey | M | - |
University of Cambridge
| 3 years |
| Michael Rogers | M | 59 |
University of Cambridge
| 4 years |
| Dong-Gun Kim | M | 77 |
University of Cambridge
| 3 years |
| Howard Chase | M | 70 |
University of Cambridge
| 22 years |
| Andrew Tomlinson | M | - |
University of Cambridge
| 4 years |
| Christopher Abell | M | - |
University of Cambridge
| 3 years |
| Stella David | F | 61 |
University of Cambridge
| 4 years |
| Andrew Hewson | M | 65 |
University of Cambridge
| 3 years |
| Clive Partridge | M | - |
University of Cambridge
| 4 years |
| Lorne Rupert Somerville | M | 60 |
University of Cambridge
| 4 years |
| Ray Hill | M | 79 |
University of Cambridge
| - |
| Mike Aspinwall | M | - |
University of Cambridge
| 4 years |
| Alan James Proto | M | 57 |
University of Cambridge
| 4 years |
| Adrian Eastwood | M | 63 |
University of Cambridge
| 4 years |
| Howard Castle-Smith | M | 65 |
University of Cambridge
| 1 years |
| Craig Neil Duncan | M | - |
University of Cambridge
| 3 years |
| Clive Swan | M | - |
University of Cambridge
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 75 | 75.00% |
| United States | 25 | 25.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thomas J. Farrell
- Personal Network
